The move, if successful, is expected to help Indian companies gain easier access to the world’s biggest pharma market.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OvmRVB
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» US may dilute norm used to delay generics
0 comments:
Post a Comment